Dongliang Wang
Research Subjects
Dongliang Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Bangkun Yang
Wuhan University, China
1 shared publication- Baohui Liu
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, People’s Republic of China
1 shared publication Daobiao Che
Department of Hospital Pharmacy Suqian First Hospital Suqian China
1 shared publicationNing Cai
Department of Hospital Pharmacy Suqian First Hospital Suqian China
1 shared publication- Qianxue Chen
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, China
1 shared publication Qing Yang
Department of Hospital Pharmacy Suqian First Hospital Suqian China
1 shared publication
Latest Publications
- Open Access
- 24 June 2020
- Published by Wiley in Food Science & Nutrition
- Vol. 8 (8) , 4151-4158
Ginsenoside Rg3 inhibits the biological activity of SGC‐7901
Aim: To explore the suppressive effects of ginsenoside Rg3 on the biological activities of gastric cancer and the mechanisms responsible therein, by conducting an in vitro study.Materials and Methods: SGC‐7901 gastric cancer cells were divided into NC, DMSO, Gin‐Low (10 mg/L), Gin‐Middle (20 mg/L), and Gin‐High (40 mg/L) groups. Using MTT, flow cytometry, transwell, and wound‐healing assays, the cell biological activities in the different groups were evaluated; the protein expression levels of PTEN, p‐PI3K, AKT, and P53 were measured by Western blot assay, and p‐PI3K nuclear volume was evaluated by immunofluorescence.Results: The SGC‐7901 cell proliferation rate was depressed significantly, and cell apoptosis increased significantly while cells were arrested in the G1 phase (p < .05) with ginsenoside Rg3 treatment in a dose‐dependent manner (p < .05). Meanwhile, the SGC‐7901 cell invasion number and wound‐healing rate of ginsenoside Rg3‐treated groups were significantly downregulated compared with those of the NC group, also in a dose‐dependent manner (p < .05). PTEN and P53 protein expression levels were significantly increased, and p‐PI3K and AKT protein expression levels were significantly depressed in ginsenoside Rg3‐treated groups in a dose‐dependent manner (p < .05).Conclusion: Ginsenoside Rg3 suppresses gastric cancer via regulation of the PTEN/p‐PI3K/AKT pathway.
- 24 June 2020
- Published by Wiley in Food Science & Nutrition
- Vol. 8 (8) , 4151-4158
Open AccessGinsenoside Rg3 inhibits the biological activity of SGC‐7901
Aim: To explore the suppressive effects of ginsenoside Rg3 on the biological activities of gastric cancer and the mechanisms responsible therein, by conducting an in vitro study.Materials and Methods: SGC‐7901 gastric cancer cells were divided into NC, DMSO, Gin‐Low (10 mg/L), Gin‐Middle (20 mg/L), and Gin‐High (40 mg/L) groups. Using MTT, flow cytometry, transwell, and wound‐healing assays, the cell biological activities in the different groups were evaluated; the protein expression levels of PTEN, p‐PI3K, AKT, and P53 were measured by Western blot assay, and p‐PI3K nuclear volume was evaluated by immunofluorescence.Results: The SGC‐7901 cell proliferation rate was depressed significantly, and cell apoptosis increased significantly while cells were arrested in the G1 phase (p < .05) with ginsenoside Rg3 treatment in a dose‐dependent manner (p < .05). Meanwhile, the SGC‐7901 cell invasion number and wound‐healing rate of ginsenoside Rg3‐treated groups were significantly downregulated compared with those of the NC group, also in a dose‐dependent manner (p < .05). PTEN and P53 protein expression levels were significantly increased, and p‐PI3K and AKT protein expression levels were significantly depressed in ginsenoside Rg3‐treated groups in a dose‐dependent manner (p < .05).Conclusion: Ginsenoside Rg3 suppresses gastric cancer via regulation of the PTEN/p‐PI3K/AKT pathway.
- Open Access
- 1 February 2016
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 31 (2) , 143-149
Ellagic acid inhibits proliferation and induces apoptosis in human glioblastoma cells
Key words: Glioblastoma; Ellagic Acid; Cell Proliferation; Apoptosis; Cell Cycle
- 1 February 2016
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 31 (2) , 143-149
Open AccessEllagic acid inhibits proliferation and induces apoptosis in human glioblastoma cells
Key words: Glioblastoma; Ellagic Acid; Cell Proliferation; Apoptosis; Cell Cycle